$CELH

Celsius Insiders Just Bought $1.8M of Stock Near Multi-Year Lows. Is the Worst Priced In?

Celsius Holdings (CELH) insiders, including CEO John Fieldly, bought $1.8M of stock between September 10-15, near multi-year lows. The company faces legal actions, shrinking flagship brand sales, and gross margin pressures. Analysts have a mid-case target of ~$45, implying a 61% total return. Q3 results in November will be key for assessing the company's recovery.

Original reporting
Published Sep 23, 2026, 9:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 10:16 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Celsius Insiders Just Bought $1.8M of Stock Near Multi-Year Lows. Is the Worst Priced In? — source image
Decision brief

The 30-second read

$CELHBullishMed
01

Why it matters

The insider purchases provide a fresh data point that may influence short‑term trading sentiment, but the underlying legal and margin issues remain unresolved.

02

Market read

Insider buying at a steep discount may attract momentum traders, but the ongoing class actions and margin concerns temper broader market enthusiasm.

03

What to watch

Potential dilution from upcoming financing or a larger settlement could offset insider confidence.

Relevance 6/10Novelty 7/10Timing: recent insider purchases reported Sep 23

Background

Celsius Holdings (CELH) has fallen ~51% over the past year amid margin warnings and pending class actions related to its Alani Nu brand.

Company-level read

Ticker impact

$CELHBullishMedium confidence
Context

SEC Form 4 disclosed three insiders bought $1.8 M of CELH shares at $27‑$28 between Sep 10‑15, the largest insider purchases in two years.

Expected impact

Potential modest upside if buying pressure continues; downside if legal issues persist.

Evidence & confidence

Purchase size is material for a micro‑cap, but legal uncertainties and margin warnings limit upside.

Market effects

Highlights risk in the energy‑drink sector; peers may see increased scrutiny over legal claims.

Limited to U.S. over‑the‑counter micro‑cap investors.

Minimal global impact; primarily a company‑specific signal.

Counterpoint

Insider buying could be a defensive move to lock in equity before further legal fallout.

Key entities

  • John Fieldly

    Purchased 18,000 shares at $27.44.

  • Damon DeSantis

    Bought 20,000 shares at $27.65 and 16,000 shares at $27.95.

  • Hal Kravitz

    Acquired 12,000 shares at $28.00.

Related articles

$CELHMed

Celsius Stock Jumps as Insiders Bet Big on Rebound

Celsius Holdings (CELH) stock rose as CEO John Fieldly and Director Damon DeSantis bought nearly $2 million in shares, and the company announced a $300 million share repurchase program. Insider buying and the buyback suggest management believes the stock is undervalued. The company's growth in the U.S. energy drink market and strong cash generation support its long-term outlook, but rising debt and thinner margins pose risks.

$CELHMed

Why Celsius (CELH) Shares Are Getting Obliterated Today

Celsius (CELH) shares fell 5.9% after Deutsche Bank downgraded the stock to Hold with a $35 target, citing weakened trends and delayed recovery. The company's Q2 results missed estimates, with revenue at $817.9M (vs. $872M expected) and EPS at $0.36 (vs. $0.42 expected). Operating margin compressed to 9.2% from 19.3% YoY. The stock is down 30.9% YTD and 49.1% from its 52-week high.

$CELHHigh

Celsius Holdings stock falls after Deutsche Bank downgrade

Celsius Holdings (CELH) shares fell 5.1% premarket Thursday after Deutsche Bank downgraded the stock to Hold from Buy, citing weak core brand performance and delayed recovery. Analyst Steve Powers raised the price target to $35 from $30 but expressed concerns about sustained growth. The stock had risen 30% in the past month, partly due to investor expectations of operational improvements.